[ACRX] QoQ Quarter Result on 31-Dec-2016 [#Q4]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
02-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 15.09%
YoY- 8.19%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 1,487 2,659 3,109 6,435 3,366 4,531 3,025 -37.68%
PBT -13,013 -13,057 -15,551 -9,682 -11,438 -11,092 -10,979 11.98%
Tax -3,233 2 -2,704 68 -36 -2,083 2 -
NP -13,013 -13,059 -15,551 -9,682 -11,402 -11,092 -10,981 11.97%
Tax Rate - - - - - - - -
Total Cost 14,500 15,718 18,660 16,117 14,768 15,623 14,006 2.33%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin -875.12 -491.12 -500.19 -150.46 -338.74 -244.80 -363.01 79.69%
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
EPS -5.61 -5.76 -6.86 -4.27 -5.03 -4.90 -4.85 10.18%
EPS Diluted -5.61 -5.76 -6.86 -4.27 -5.03 -4.90 -4.85 10.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.